Cencora医药 COR
$333.56 −$6.12 (-1.80%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $333.56 0.00%
开盘$333.61
昨收$339.68
当日区间$332.67 – $338.54
成交量1.68M
市值$63.65B
市盈率（TTM）18.6
股息率0.72%
COR 相关新闻
匹配 Cencora 或代码 COR 的头条新闻，按最新排序。
- Morgan Stanley Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $346 正面
- A Quick Look at Today's Ratings for Cencora(COR.US), With a Forecast Between $346 to $430
- A Quick Look at Today's Ratings for Cencora(COR.US), With a Forecast Between $350 to $430
- China Taiping Insurance (601601) 2026 Interim Report Commentary: Life insurance NBV benefits from improved value margin, while property insurance COR has improved markedly.
- Cencora(COR.US) Officer Sells US$3.66 Million in Common Stock
- Ping An (601318) Commentary: Profit growth exceeded expectations; OPAT, NBV, and COR were in line with forecasts. 正面
- RBC Capital Initiates Cencora(COR.US) With Hold Rating, Announces Target Price $330
- Barclays Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $350
- Evercore Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $350
- J.P. Morgan Maintains Cencora(COR.US) With Buy Rating, Cuts Target Price to $390 负面
- Wells Fargo Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $395 正面
- J.P. Morgan Sticks to Their Buy Rating for Cencora (COR)
- TD Cowen Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $400
- BofA Securities Maintains Cencora(COR.US) With Hold Rating
- BofA Securities Maintains Cencora(COR.US) With Hold Rating, Announces Target Price $310
暂无评论——快来第一个聊聊 COR。
登录后参与讨论。